These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 28105116

  • 21. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W, Muley T, Herb KP, Schmidt-Gayk H.
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [Abstract] [Full Text] [Related]

  • 22. Radiological impact of oral bisphosphonate use on polyostotic Paget's disease of bone over a 2 year period.
    Pinto CJ, Maldar SB, Hegde S, Choukimath SM.
    Radiol Case Rep; 2024 May; 19(5):1886-1892. PubMed ID: 38434784
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of a revised version of computer-assisted diagnosis system, BONENAVI version 2.1.7, for bone scintigraphy in cancer patients.
    Koizumi M, Miyaji N, Murata T, Motegi K, Miwa K, Koyama M, Terauchi T, Wagatsuma K, Kawakami K, Richter J.
    Ann Nucl Med; 2015 Oct; 29(8):659-65. PubMed ID: 26033528
    [Abstract] [Full Text] [Related]

  • 24. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.
    Chung JH, Park MS, Kim YS, Chang J, Kim JH, Kim SK, Kim SK.
    Yonsei Med J; 2005 Jun 30; 46(3):388-93. PubMed ID: 15988811
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
    Morris PG, Fazio M, Farooki A, Estilo C, Mallam D, Conlin A, Patil S, Fleisher M, Cremers S, Huryn J, Hudis CA, Fornier MN.
    J Oral Maxillofac Surg; 2012 Dec 30; 70(12):2768-75. PubMed ID: 22330331
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Quantitative Bone Single Photon Emission Computed Tomography/Computed Tomography for Evaluating Response to Bisphosphonate Treatment in Patients with Paget's Disease of Bone.
    Kitajima K, Futani H, Tsuchitani T, Takahashi Y, Yamakado K.
    Case Rep Oncol; 2020 Dec 30; 13(2):829-834. PubMed ID: 32884526
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Components of biological variation of biochemical markers of bone turnover in Paget's bone disease.
    Alvarez L, RicOs C, Peris P, GuaNabens N, Monegal A, Pons F, Ballesta AM.
    Bone; 2000 Jun 30; 26(6):571-6. PubMed ID: 10831927
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
    Takahara K, Kamimura M, Hashidate H, Uchiyama S, Nakagawa H.
    J Orthop Sci; 2007 May 30; 12(3):219-26. PubMed ID: 17530373
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Course of NTX changes under continuous bisphosphonate treatment in cases of NTX over-reduction due to long-term treatment with bisphosphonates.
    Iba K, Takada J, Sasaki K, Wada T, Yamashita T.
    J Orthop Sci; 2011 Jan 30; 16(1):71-6. PubMed ID: 21290152
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.